Use of oral vasopressin V2 receptor antagonist for hyponatremia in acute brain injury.
نویسندگان
چکیده
a Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul , Republic of Korea; b Departments of Neurosurgery and Neurology, The University of Texas Medical School at Houston, Houston, Tex. , c Department of Neurology, University of Maryland School of Medicine, Baltimore, Md. , and Departments of d Neurology and e Pharmacy, Columbia University College of Physicians and Surgeons,
منابع مشابه
Ecstasy (MDMA) and its effects on kidneys and their treatment: a review
Ecstasy (MDMA; 3,4-methylenedioxymethylamphetamine) is an illicit drug that has been increasingly abused by young people. Its effects include euphoria, enhanced sociability and heightened mental awareness. These come about via the increase of serotonin in both the central nervous system and the sympathetic nervous system. Despite the drug’s prevalent abuse, serious or adverse effects are rare. ...
متن کاملPersistent syndrome of inappropriate antidiuretic hormone secretion following traumatic brain injury
UNLABELLED The syndrome of inappropriate antidiuretic hormone secretion (SIADH) can occur following traumatic brain injury (TBI), but is usually transient. There are very few case reports describing chronic SIADH and all resolved within 12 months, except for one case complicated by meningo-encephalitis. Persistent symptomatic hyponatremia due to chronic SIADH was present for 4 years following a...
متن کاملVasopressin and Vasopressin Receptor Antagonists
Vasopressin, a neurohypophyseal peptide hormone, is the endogenous agonist at V1a, V1b, and V2 receptors. The most important physiological function of vasopressin is the maintenance of water homeostasis through interaction with V2 receptors in the kidney. Vasopressin binds to V2 receptor and increases the number of aquaporin-2 at the apical plasma membrane of collecting duct principal cells. Th...
متن کاملAquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients.
OBJECTIVES The purpose of this study was to examine the renal effects of a V2 receptor arginine vasopressin (AVP) antagonist in heart failure. BACKGROUND Arginine vasopressin has been implicated in the renal water retention and dilutional hyponatremia associated with chronic heart failure. METHODS We examined the effects of the oral, non-peptide, selective V2 receptor antagonist lixivaptan ...
متن کاملRole of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome.
The pathogenesis of cardiac failure involves activation of the neurohumoral axis including stimulation of the sympathetic nervous system, the renin-angiotensin-aldosterone, and nonosmotic vasopressin systems. While these responses are critical in maintaining arterial pressure, they are associated with renal vasoconstriction, as well as sodium and water retention. In advanced circumstances, rena...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- European neurology
دوره 70 3-4 شماره
صفحات -
تاریخ انتشار 2013